Høgestøl EA, Brustad ÅW, Celius EG, Meling M, Berg-Hansen P, Kro GB, König M, Schanke Y, Halvorsen B, Warren DJ, Gehin JE, Bolstad N, Nygaard GO (2026)
Serum drug levels and JCV assay discrepancies after switching from originator to biosimilar natalizumab
BMJ Neurol Open, 8 (1), e001477
DOI 10.1136/bmjno-2025-001477, PubMed 41877736

Rasmussen TH, Schikora-Rustad S, Lorentzen ÅR, Tran TT, Øverås MH, Myhr KM, Wergeland S, Aarseth J, Bø L, Berge T, Høgestøl EA, Harbo HF, Tveter AT, Jørgensen KK, Cunen C, Torkildsen Ø, Holmøy T, Celius EG, Vaage JT, Nygaard GO, Lund-Johansen F, König M (2026)
Low risk of severe COVID-19 in vaccinated people with multiple sclerosis: a nationwide Norwegian study
BMJ Neurol Open, 8 (1), e001556
DOI 10.1136/bmjno-2026-001556, PubMed 41835014

Høgestøl EA, Sowa P, Holmøy T, Bø L, Nygaard GO, Wergeland S (2025)
Revised diagnostic criteria for multiple sclerosis
Tidsskr Nor Laegeforen, 145 (15)
DOI 10.4045/tidsskr.25.0592, PubMed 41410973